Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 20   

Articles published

TENX 4.00 +0.07 (1.78%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics ...
�We are very pleased to unveil this new company name as we continue moving forward as Tenax Therapeutics,� said John Kelley, Chief Executive Officer.
Beleagured Morrisville drug developer changes name, sharpens focus  Triangle Business Journal
Related articles »  
Achillion Pharmaceuticals Inc (ACHN), Tenax Therapeutics Inc (TENX): Peter ...
As a result, RA Capital Management is left holding 8.03 million shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In another move, the fund's manager, Peter Kolchinsky, has initiated a position in Tenax Therapeutics Inc (NASDAQ:TENX). According ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics Q1 Loss Narrows - Quick Facts  NASDAQ
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
MORRISVILLE, N.C., Sep 22, 2014 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, +0.51% formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical ...
Tenax Therapeutics Enrolls First Patients In Phase 3 Trial For Levosimendan  RTT News
Related articles »  
Tenax Therapeutics Inc.: Tenax Therapeutics to Provide Corporate Update and ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., today announced that the Company will host a conference call and live audio webcast on Wednesday, September 24, 2014, at 8:30 ...
Related articles »  
Tenax Therapeutics Q1 15 Earnings Conference Call At 8:30 AM ET
(RTTNews.com) - Tenax Therapeutics Inc ( TENX ) will host a conference call at 8:30 AM ETSeptember 24, 2014, to discuss its Q1 15 earnings results.
Stocks Buzz- Lattice Semiconductor (NASDAQ:LSCC), Oxygen ...
... a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, declared that the Company received shareholder approval to change the Company name to Tenax Therapeutics, Inc. The ...
Related articles »